Company intelligence / Profile preview
EPIK Biosciences
Austin, Texas, United Statesepikbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
EPIK Biosciences is a psychedelic drug development company focused on building a portfolio of proprietary ketamine- and dextromethorphan (DXM)-based combination therapies. Founded in 2026 and based in Austin, Texas, the company leverages a proprietary platform rooted in NMDA receptor modulation to engineer synergistic co-delivery formulations. These therapies target mental health disorders (such as depression, anxiety, and PTSD), severe and chronic pain, and substance use disorders. By utilizing already FDA-approved, non-Schedule I compounds, EPIK aims to establish a lower-risk, expedited regulatory pathway (such as 505(b)(2)) for patient-friendly, at-home delivery formats like sublingual films, lozenges, and topical applications.
- Therapeutic areas
- RheumatologyPsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
LabcorpCasimir Jones
Beyond the preview
Go deeper on EPIK Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EPIK Biosciences.